Log in

Immunome Stock Forecast, Price & News

-0.20 (-1.73 %)
(As of 10/30/2020 12:00 AM ET)
Today's Range
Now: $11.35
50-Day Range N/A
52-Week Range
Now: $11.35
Volume4,850 shs
Average Volume43,778 shs
Market Capitalization$2.62 billion
P/E RatioN/A
Dividend YieldN/A
Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.30 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Current SymbolNASDAQ:IMNM
Phone610 321 3700



Sales & Book Value

Annual SalesN/A



Market Cap$2.62 billion
Next Earnings DateN/A
OptionableNot Optionable
-0.20 (-1.73 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IMNM News and Ratings via Email

Sign-up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Immunome (NASDAQ:IMNM) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Immunome?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Immunome in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Immunome

What price target have analysts set for IMNM?

2 analysts have issued 12 month target prices for Immunome's shares. Their forecasts range from $18.00 to $18.00. On average, they expect Immunome's stock price to reach $18.00 in the next year. This suggests a possible upside of 58.6% from the stock's current price.
View analysts' price targets for Immunome

Who are some of Immunome's key competitors?

Who are Immunome's key executives?

Immunome's management team includes the following people:
  • Dr. Purnanand Duddu Sarma, Pres, CEO & Director (Age 55)
  • Mr. Richard F. Fitzgerald, Chief Financial Officer (Age 56)
  • Dr. Michael J. Morin, Chief Scientific Officer (Age 65)
  • Mr. Matthew K. Robinson Ph.D., Sr. VP of R&D

When did Immunome IPO?

(IMNM) raised $30 million in an initial public offering on Friday, October 2nd 2020. The company issued 2,500,000 shares at $11.00-$13.00 per share. Ladenburg Thalmann and Chardan acted as the underwriters for the IPO.

What is Immunome's stock symbol?

Immunome trades on the NASDAQ under the ticker symbol "IMNM."

When does Immunome's quiet period expire?

Immunome's quiet period expires on Wednesday, November 11th. Immunome had issued 3,250,000 shares in its initial public offering on October 2nd. The total size of the offering was $39,000,000 based on an initial share price of $12.00. During Immunome's quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Immunome?

Shares of IMNM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Immunome's stock price today?

One share of IMNM stock can currently be purchased for approximately $11.35.

How big of a company is Immunome?

Immunome has a market capitalization of $2.62 billion. Immunome employs 21 workers across the globe.

What is Immunome's official website?

The official website for Immunome is immunome.com.

How can I contact Immunome?

The company can be reached via phone at 610 321 3700.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.